The pneumococcal polysaccharide capsule and pneumolysin differentially affect CXCL8 and IL-6 release from cells of the upper and lower respiratory tract.

Eitemau Tebyg

• The Pneumococcal Polysaccharide Capsule and Pneumolysin Differentially Affect CXCL8 and IL-6 Release from Cells of the Upper and Lower Respiratory Tract
  gan: Küng, Eliane, et al.
  Cyhoeddwyd: (2014)
• Circulating Pneumolysin Is a Potent Inducer of Cardiac Injury during Pneumococcal Infection
  gan: Alhamdi, Yasir, et al.
  Cyhoeddwyd: (2015)
• CD4-T-Lymphocyte Interactions with Pneumolysin and Pneumococci Suggest a Crucial Protective Role in the Host Response to Pneumococcal Infection
  gan: Kadioglu, Aras, et al.
  Cyhoeddwyd: (2004)
• Polysaccharide Capsule Composition of Pneumococcal Serotype 19A Subtypes Is Unaltered among Subtypes and Independent of the Nutritional Environment
  gan: Brugger, Silvio D., et al.
  Cyhoeddwyd: (2016)
• Upper and Lower Respiratory Tract Infection by Streptococcus pneumoniae Is Affected by Pneumolysin Deficiency and Differences in Capsule Type
  gan: Kadioglu, Aras, et al.
  Cyhoeddwyd: (2002)